Health Care & Life Sciences » Biotechnology | Sirona Biochem Corp.

Sirona Biochem Corp.

Sirona Biochem Corp.
Stock Exchange Other OTC
EPS
$0.01
Market Cap
$73.45 M
Shares Outstanding
172.23 M
Public Float
-
Sirona Biochem Corp.
Stock Exchange Frankfurt Stock Exchange
EPS
EUR0.01
Market Cap
EUR70.16 M
Shares Outstanding
172.23 M
Public Float
-
Sirona Biochem Corp.
Stock Exchange Toronto Ventures Stock Exchange
EPS
CAD0.01
Market Cap
CAD96.29 M
Shares Outstanding
207.07 M
Public Float
151.91 M

Profile

Address
595 Burrard Street
Vancouver British Columbia V7X 1L3
Canada
Employees -
Website http://www.sironabiochem.com
Updated 07/08/2019
Sirona Biochem Corp. engages in the development of diabetes therapeutics, skin depigmenting, and anti-aging agents for cosmetic use, biological ingredients, and cancer vaccine antigens. It also involves in utilizing a proprietary chemistry technique to improve pharmaceutical properties of carbohydrate-based molecules. The company was founded by Howard Jarman Verrico on October 19, 2006 and is headquartered in Vancouver, Canada.

Financials

View All

Howard Jarman Verrico
Chairman, Chief Executive Officer & Secretary
Christopher D. Hopton
Chief Financial Officer & Director